Question 1

Am I eligible for this trial based on my previous treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer clinical trial (NCT00334802). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of gemcitabine and paclitaxel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer clinical trial (NCT00334802). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to what I am currently receiving?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer clinical trial (NCT00334802). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer clinical trial (NCT00334802). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer clinical trial (NCT00334802). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer clinical trial (NCT00334802). Contact the study team or your healthcare provider for specific answers.

What this study is about